EATG » Scientific research

Scientific research

Gilead announces findings from new preclinical study evaluating novel class of HIV capsid inhibitors

– Findings support continued investigation of inhibitor class as part of a long-acting antiretroviral HIV treatment strategy – SEATTLE, Feb. 13, 2017-- Gilead Sciences, Inc. (NASDAQ:GILD) today announced findings from…

Seattle-lite: pre-conference workshops – watch online

The commitment to providing all presentations online as open access educational resources is one of the most impressive aspect of the annual CROI meetings. Options include to watch the presentations…

Collaboration on novel cellular therapies for long term HIV control

Bioquark Inc. and SC21 Biotech are collaborating on novel cellular therapies for long term HIV control by cost effectively and industrially scaling the production of HIV resistant cells for allogeneic…

Genetics of both virus and patient work together to influence the course of HIV infection

A patient's genetics may impact disease progression by inducing mutations in the HIV genome Viral and human genetics together account for about one third of the differences in disease progression…

New drug screening system could help speed development of a cure for HPV

Scientists have used genetic engineering techniques to develop a new system that could aid identification of potential drug targets and treatments for human papillomavirus (HPV) infection, according to a PLOS…

‘Keeping the foot on the gas’ of HIV research at CROI 2017

SEATTLE — When controversies arise, researchers return to the science. So at the Conference on Retroviruses and Opportunistic Infections (CROI) 2017, which will convene next week amid funding concerns and…

HIVACAR takes off to find cure for HIV

Hospital Clinic-IDIBAPS coordinates a European project to obtain a functional cure for HIV with immunotherapy The IDIBAPS and the Hospital Clínic of Barcelona lead a European project aimed at changing…

Phase I clinical data of ABX464, ABIVAX’s first-in-class anti-HIV drug, published in two articles in peer-reviewed journals

PARIS, February 02, 2017 - ABIVAX (Paris:ABVX) (Euronext Paris: FR0012333284 – ABVX), an innovative biotechnology company targeting the immune system to eliminate viral diseases, announced today that the previously disclosed…

Novel pharmaceutic action for HIV/AIDS discovered

A research team at UNMC has used a process they call LASER ART (long-acting slow effective release antiretroviral therapy) to discover an unexpected pathway to open cell storage areas for…

Can a novel combination of treatments help eradicate HIV?

In first-ever study, Case School of Medicine researchers to pair monoclonal antibody with body’s own killer-cell stimulator Newswise — A Case Western Reserve University School of Medicine researcher has received…